BioRestorative Reports Positive Phase 2 Data for BRTX-100 in Chronic Lumbar Disc Disease
BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease MELVILLE, N.Y., March 30, 2026 — BioRestorative Therapies, Inc.…
